| Year |
Citation |
Score |
| 2023 |
LaMarche NM, Hegde S, Park MD, Maier BB, Troncoso L, Le Berichel J, Hamon P, Belabed M, Mattiuz R, Hennequin C, Chin T, Reid AM, Reyes-Torres I, Nemeth E, Zhang R, et al. An IL-4 signalling axis in bone marrow drives pro-tumorigenic myelopoiesis. Nature. PMID 38057662 DOI: 10.1038/s41586-023-06797-9 |
0.64 |
|
| 2023 |
Magen A, Hamon P, Fiaschi N, Soong BY, Park MD, Mattiuz R, Humblin E, Troncoso L, D'souza D, Dawson T, Kim J, Hamel S, Buckup M, Chang C, Tabachnikova A, ... ... Hegde S, et al. Intratumoral dendritic cell-CD4 T helper cell niches enable CD8 T cell differentiation following PD-1 blockade in hepatocellular carcinoma. Nature Medicine. PMID 37322116 DOI: 10.1038/s41591-023-02345-0 |
0.69 |
|
| 2023 |
Park MD, Reyes-Torres I, LeBerichel J, Hamon P, LaMarche NM, Hegde S, Belabed M, Troncoso L, Grout JA, Magen A, Humblin E, Nair A, Molgora M, Hou J, Newman JH, et al. TREM2 macrophages drive NK cell paucity and dysfunction in lung cancer. Nature Immunology. PMID 37081148 DOI: 10.1038/s41590-023-01475-4 |
0.542 |
|
| 2021 |
Hegde S. Pancreatic Cancer Immuno-oncology in the Era of Precision Medicine. Indian Journal of Surgical Oncology. 12: 118-127. PMID 33994737 DOI: 10.1007/s13193-020-01192-6 |
0.347 |
|
| 2021 |
Hegde S, Leader AM, Merad M. MDSC: Markers, development, states, and unaddressed complexity. Immunity. 54: 875-884. PMID 33979585 DOI: 10.1016/j.immuni.2021.04.004 |
0.694 |
|
| 2020 |
Vabret N, Britton GJ, Gruber C, Hegde S, Kim J, Kuksin M, Levantovsky R, Malle L, Moreira A, Park MD, Pia L, Risson E, Saffern M, Salomé B, Esai Selvan M, et al. Immunology of COVID-19: Current State of the Science. Immunity. PMID 32505227 DOI: 10.1016/J.Immuni.2020.05.002 |
0.407 |
|
| 2020 |
Hegde S, Krisnawan VE, Herzog BH, Zuo C, Breden MA, Knolhoff BL, Hogg GD, Tang JP, Baer JM, Mpoy C, Lee KB, Alexander KA, Rogers BE, Murphy KM, Hawkins WG, et al. Dendritic Cell Paucity Leads to Dysfunctional Immune Surveillance in Pancreatic Cancer. Cancer Cell. 37: 289-307.e9. PMID 32183949 DOI: 10.1016/J.Ccell.2020.02.008 |
0.691 |
|
| 2019 |
Panni RZ, Herndon JM, Zuo C, Hegde S, Hogg GD, Knolhoff BL, Breden MA, Li X, Krisnawan VE, Khan SQ, Schwarz JK, Rogers BE, Fields RC, Hawkins WG, Gupta V, et al. Agonism of CD11b reprograms innate immunity to sensitize pancreatic cancer to immunotherapies. Science Translational Medicine. 11. PMID 31270275 DOI: 10.1126/Scitranslmed.Aau9240 |
0.701 |
|
| 2019 |
Jiang H, Liu X, Knolhoff BL, Hegde S, Lee KB, Jiang H, Fields RC, Pachter JA, Lim KH, DeNardo DG. Development of resistance to FAK inhibition in pancreatic cancer is linked to stromal depletion. Gut. PMID 31076405 DOI: 10.1136/gutjnl-2018-317424 |
0.541 |
|
| 2017 |
Jiang H, Hegde S, DeNardo DG. Tumor-associated fibrosis as a regulator of tumor immunity and response to immunotherapy. Cancer Immunology, Immunotherapy : Cii. PMID 28451791 DOI: 10.1007/s00262-017-2003-1 |
0.631 |
|
| 2016 |
Jiang H, Hegde S, Knolhoff BL, Zhu Y, Herndon JM, Meyer MA, Nywening TM, Hawkins WG, Shapiro IM, Weaver DT, Pachter JA, Wang-Gillam A, DeNardo DG. Targeting focal adhesion kinase renders pancreatic cancers responsive to checkpoint immunotherapy. Nature Medicine. PMID 27376576 DOI: 10.1038/Nm.4123 |
0.702 |
|
| Show low-probability matches. |